, Collaborative Group on Hormonal Factors in Breast C. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies, Lancet, vol.347, pp.1713-1740, 1996.
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions, Br J Cancer, vol.98, pp.1457-66, 2008. ,
Genetic testing for familial/hereditary breast cancercomparison of guidelines and recommendations from the UK, France, The Netherlands and Germany, J Community Genet, vol.2, pp.53-69, 2011. ,
Panel testing for familial breast cancer: calibrating the tension between research and clinical care, J Clin Oncol, vol.34, pp.1455-1464, 2016. ,
A PALB2 mutation associated with high risk of breast cancer, Breast Cancer Res, vol.12, p.109, 2010. ,
which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nat Genet, vol.39, pp.165-172, 2007. ,
Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer, Cancer Res, vol.71, pp.2222-2231, 2011. ,
Breast-cancer risk in families with mutations in PALB2, N Engl J Med, vol.371, pp.497-506, 2014. ,
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer, Am J Hum Genet, vol.85, pp.427-473, 2009. ,
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles, Nat Genet, vol.38, pp.873-878, 2006. ,
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study, Breast Cancer Res, vol.13, p.6, 2011. ,
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nat Genet, vol.42, pp.410-414, 2010. ,
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers, Eur J Hum Genet, vol.25, pp.1345-53, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02194429
Rare mutations in XRCC2 increase the risk of breast cancer, Am J Hum Genet, vol.90, pp.734-743, 2012. ,
Rare mutations in RINT1 predispose carriers to breast and lynch syndrome-spectrum cancers, Cancer Discov, vol.4, pp.804-819, 2014. ,
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study, Breast Cancer Res, vol.16, p.58, 2014. ,
Rare variants in XRCC2 as breast cancer susceptibility alleles, J Med Genet, vol.49, pp.618-638, 2012. ,
Reevaluation of RINT1 as a breast cancer predisposition gene, Breast Cancer Res Treat, vol.159, pp.385-92, 2016. ,
Genepanel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-57, 2015. ,
Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database, Cancer, vol.118, pp.1387-96, 2012. ,
Growing recognition of the role for rare missense substitutions in breast cancer susceptibility, Biomark Med, vol.8, pp.589-603, 2014. ,
GENESIS: a French national resource to study the missing heritability of breast cancer, BMC Cancer, vol.16, p.13, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01662200
A simple and efficient non-organic procedure for the isolation of genomic DNA from blood, Nucleic Acids Res, vol.17, p.8390, 1989. ,
Fast and accurate long-read alignment with burrows-wheeler transform, Bioinformatics, vol.26, pp.589-95, 2010. ,
Haplotype-based variant detection from short-read sequencing. ar Xiv. preprint, ArXiv, vol.1207, p.3907, 2012. ,
The genome analysis toolkit: a map reduce framework for analyzing next-generation DNA sequencing data, Genome Res, vol.20, pp.1297-303, 2010. ,
Integrative genomics viewer, Nat Biotechnol, vol.29, pp.24-30, 2011. ,
Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration, Brief Bioinform, vol.14, pp.178-92, 2013. ,
Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res, vol.20, pp.110-131, 2010. ,
Predicting deleterious amino acid substitutions, Genome Res, vol.11, pp.863-74, 2001. ,
Sunyaev SR. predicting functional effect of human missense mutations using poly Phen-2, Curr Protoc Hum Genet. Chapter, vol.7, p.20, 2013. ,
A general framework for estimating the relative pathogenicity of human genetic variants, Nat Genet, vol.46, pp.310-315, 2014. ,
Classification of rare missense substitutions, using risk surfaces, with genetic-and molecularepidemiology applications, Hum Mutat, vol.29, pp.1342-54, 2008. ,
Germline mutations causing familial lung cancer, J Hum Genet, vol.60, pp.597-603, 2015. ,
Functionally recurrent rearrangements of the MAST kinase and notch gene families in breast cancer, Nat Med, vol.17, pp.1646-51, 2011. ,
Molecular genetics of Xeroderma pigmentosum variant, Exp Dermatol, vol.12, pp.529-565, 2003. ,
Diagnosis of Xeroderma pigmentosum variant in a young patient with two novel mutations in the POLH gene, Am J Med Genet A, vol.173, pp.2511-2517, 2017. ,
Nextgeneration sequencing in familial breast cancer patients from Lebanon, BMC Med Genomics, vol.10, p.8, 2017. ,
Clinical and molecular heterogeneity of RTEL1 deficiency, Front Immunol, vol.8, p.449, 2017. ,
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis, Eur Respir J, vol.46, pp.474-85, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01214563
Rare variants in RTEL1 are associated with familial interstitial pneumonia, Am J Respir Crit Care Med, vol.191, pp.646-55, 2015. ,
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening, Nat Genet, vol.47, pp.512-519, 2015. ,
Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies, Haematologica, vol.102, pp.293-299, 2017. ,
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry (CFR) case-control mutation screening study, Breast Cancer Res, vol.13, p.6, 2011. ,
Rare germline mutations in PALB2 and breast cancer risk: a population-based study, Hum Mutat, vol.33, pp.674-80, 2012. ,
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families, Breast Cancer Res, vol.15, p.17, 2013. ,
Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c. 1066-6T>G (IVS10-6T>G) from the breast cancer family registry, Hum Mutat, vol.27, pp.1122-1130, 2006. ,
Rare variants in the ATM gene and risk of breast cancer, Breast Cancer Res: BCR, vol.13, p.73, 2011. ,
CHEK2 and ATM rare variants and cancer risk: data from COGS, J Med Genet, vol.53, pp.800-811, 2016. ,
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees, Nat Genet, vol.30, pp.97-101, 2002. ,
Breast cancerassociated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair, Oncogene, vol.33, pp.4803-4815, 2014. ,
The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk, Breast Cancer Res, vol.18, p.111, 2016. ,
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer, Hum Mutat, vol.32, pp.2176-88, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00616697
ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res, vol.42, pp.980-985, 2014. ,
Using ClinVar as a resource to support variant interpretation, Curr Protoc Hum Genet, vol.89, pp.8-16, 2016. ,